Back to Back Issues Page
Anti-Inflammatory and Anti-Angiogenic Therapy
April 21, 2015

Anti-Inflammatory and Anti-Angiogenic Therapy

Radiation therapy to treat rapidly dividing cancer cells has long been a standard of treatment. That same therapy is now being used to treat wet age-related macular degeneration.

Oraya, Inc.

Oraya Therapeutics, Inc, sponsored the first double-blind, sham controlled clinical trial to evaluate the safety and the effectiveness of a one time low dose radiation treatment in addition to Lucentis or Avastin eye injections as a therapy for wet AMD.

Results are now being published showing positive outcomes. According to the Oraya, Inc website,

"Recent clinical studies have demonstrated a 32% reduction in the injection burden with the potential for certain patients to experience more than a 50% drop in their need for anti-VEGF medications."

Ionizing radiation has been found to have anti-angiogenic and anti-inflammatory effects, both of which impact the progression of wet AMD.

Watch a brief video on how this stereotactic radiation works for those with AMD and what kind of benefits patients are experiencing:

Stereotactic Radiation - Anti-Inflammatory and Anti-Angiogenic Therapy

Leslie Degner, RN, BSN

Better Health for Better Vision

Back to Back Issues Page